Home › Overweight › Minnesota › Minneapolis
Overweight clinical trials in Minneapolis, MN
6 studies for Overweight are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
RecruitingPhase 3
- International Diabetes Center At Park Nicollet, Minneapolis
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RecruitingPhase 3
- University of Minnesota Masonic Children's Hospital, Minneapolis
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
RecruitingPhase 3Healthy volunteers welcome
- ACCOMPLISH-2 Research Site, Minneapolis
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
RecruitingPhase 3
- University of Minnesota, Minneapolis
A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity
RecruitingPhase 4
- Clinical Research Institute of Minnesota, Minneapolis
Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
Recruiting
- Minneapolis VA Health Care System, Minneapolis
Overweight trials in other cities
- San Antonio, TX34 studies
- Houston, TX33 studies
- Chicago, IL29 studies
- Orlando, FL27 studies
- Dallas, TX23 studies
- Miami, FL23 studies
- Washington, DC20 studies
- Atlanta, GA20 studies
- Austin, TX19 studies
- Las Vegas, NV19 studies
- Jacksonville, FL19 studies
- New York City, NY19 studies
Other studies in Minneapolis
- Non-Small Cell Lung Cancer29 studies
- Breast Cancer23 studies
- Ovarian Cancer23 studies
- Prostate Cancer22 studies
- Heart Failure22 studies
- Cancer (all types)21 studies
- Endometrial Cancer20 studies
- Colorectal Cancer20 studies
- Lung Cancer20 studies
- Acute Myeloid Leukemia19 studies
- Parkinson's Disease17 studies
- Coronary Artery Disease15 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.